Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

More News

Copper Cools After Record January—But This ETF Is a Buy-the-Dip Opportunity ↗

March 22, 2026

Via MarketBeat

Is Reddit's Stock Collapse a Buying Opportunity? ↗

March 22, 2026

Via MarketBeat

Trash to Treasure: 3 Waste Removal Stocks to Minimize Volatility ↗

March 22, 2026

Via MarketBeat

Can SoFi Shares Thrive Through Maturity? ↗

March 22, 2026

Via MarketBeat

Circle May Be the Biggest Winner of America’s Stablecoin Shift ↗

March 22, 2026

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	205.37	+0.00 (0.00%)
AAPL	247.99	+0.00 (0.00%)
AMD	201.33	+0.00 (0.00%)
BAC	47.16	+0.00 (0.00%)
GOOG	298.79	+0.00 (0.00%)
META	593.66	+0.00 (0.00%)
MSFT	381.87	+0.00 (0.00%)
NVDA	172.70	+0.00 (0.00%)
ORCL	149.68	+0.00 (0.00%)
TSLA	367.96	+0.00 (0.00%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.